Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Maternal cannabis use puts kids at risk of behavioural problems

Children exposed to their mother's cannabis use during pregnancy and after birth are three...

Content from other channels on our network

Western Sydney Local Health District prosecution withdrawn

Bankstown-Lidcombe and Liverpool Hospitals trial body cameras

Brain and kidney injury treatment after cardiac surgery

Thousands of NSW public hospital doctors to strike next week

Gentle care practices to help reduce pressure injury risk factors

Wannon Water solves pump blockage issue

STABILISOR tech revolutionises air compressor operation

Kate Ceberano helps raise over $580,000 for clean water

Consult Australia Awards — winners announced

Land water loss causes sea level rise in 21st century

Norco's fresh full cream milk wins Canstar Blue award

Visy trials its new recyclable fibre-based thermal insulation

What's new on the shelf: new food products for Easter

Hygienic design for food production automation systems

Detection and Quantification of Lactose in Dairy Products